All stock lists
Immucell Corp /De/ (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
Healthcare · Biotechnology
$11.42+$0.67 (+6.23%)
Insider Score
––Not scored
ICCC Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ICCC Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $8.04 M | $7.19 M | $10.36 M | $7.63 M | $5.51 M |
| Revenue Growth (YoY) | 46.02 % | — | — | — | — |
| Cost of Revenue | $4.48 M | $4.75 M | $5.70 M | $4.72 M | $3.14 M |
| Gross Profit | $3.56 M | $2.44 M | $4.66 M | $2.91 M | $2.36 M |
| SG&A Expense | $2.42 M | $2.38 M | $2.37 M | $2.21 M | $1.65 M |
| R&D Expense | $176.77 K | $119.65 K | $317.69 K | $758.86 K | $694.31 K |
| Operating Expenses | $2.60 M | $502.29 K | $2.69 M | $2.97 M | $2.34 M |
| Operating Income | $957.77 K | $1.93 M | $1.97 M | -$57.96 K | $20.07 K |
| Pretax Income | $935.27 K | $1.88 M | $1.95 M | -$2.85 M | -$135.29 K |
| Tax Provision | -$17.23 K | $45.95 K | $12.52 K | $3.31 K | $4.46 K |
| Net Income | $952.51 K | $1.83 M | $1.94 M | -$2.85 M | -$139.75 K |
| EPS (Basic) | $0.10 | $0.20 | $0.21 | -$0.31 | -$0.02 |
| EPS (Diluted) | $0.10 | $0.20 | $0.21 | -$0.31 | -$0.02 |
| Shares Outstanding | 9.08 M | 9.06 M | 9.05 M | 9.05 M | 9.05 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
